The effects of metformin and letrozole on endometrium and ovary in a rat model

Gynecological Endocrinology

Volumn 27, Issue 12, 2011, Pages 1084-1086

  Oner, Gokalp ^a   Ozcelik, Bulent ^a   Ozgun, Mahmut Tuncay ^a   Ozturk, Figen ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

endometrium; letrozole; Metformin; ovary

Indexed keywords

GLIFOR; LETROZOLE; METFORMIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; ENDOMETRIUM; FEEDING; FEMALE; LOW DRUG DOSE; NONHUMAN; OVARY; OVARY FOLLICLE; PRIORITY JOURNAL; RAT; WISTAR ALBINO GLAXO RAT;

ANIMALS; AROMATASE INHIBITORS; CELL COUNT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG EVALUATION, PRECLINICAL; ENDOMETRIUM; FEMALE; FERTILITY AGENTS, FEMALE; HYPOGLYCEMIC AGENTS; METFORMIN; MODELS, ANIMAL; NITRILES; ORGAN SIZE; OVARY; RATS; RATS, WISTAR; TRIAZOLES;

EID: 80955143866     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2011.589928     Document Type: Article

References (21)

1. Lass A. Assessment of ovarian reserve: is there still a role for ovarian biopsy in the light of new data? Hum Reprod 2004;19:467-469.
2. Legro RS, Zaino RJ, Demers LM, Kunselman AR, Gnatuk CL, Williams NI, Dodson WC. The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome. Am J Obstet Gynecol;2007;196:402.
3. Hardiman P, Pillay OC, Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet 2003;361:1810-1812.
4. Oner G, Ozcelik B, Ozgun MT, Serin IS, Ozturk F, Basbug M. The effects of metformin and letrozole on endometriosis and comparison of the two treatment agents in a rat model. Hum Reprod 2010;25:932-937.
5. Erdemoglu E, Gey M, Giray SG, Take G, Mungan T. Effects of etformin on mammalian target of rapamycin in a mouse model of endometrial hyperplasia. Eur J Obstet Gynecol Reprod Biol 2009;145:195-199.
6. Cantrell LA, Zhou C, Mendivil A, Malloy KM, Gehrig PA, Bae-Jump VL. Metformin is a potent inhibitor of endometrial cancer cell proliftion- implications for a novel treatment strategy. Gynecol Oncol 2010;116:92-98.
7. Takemura Y, Osuga Y, Yoshino O, Hasegawa A, Hirata T, Hirota Y, Nose E, et al. Metformin suppresses interleukin (IL)-1beta-induced IL-8 production, aromatase activation, and proliftion of endometriotic stromal cells. J Clin Endocrinol Metab 2007;92:3213-3218.
8. Randolph JF Jr, Kipersztok S, Ayers JW, Ansbacher R, Peegel H, Menon KM. The effect of insulin on aromatase activity in isolated human endometrial glands and stroma. Am J Obstet Gynecol 1987;157:1534-1539.
9. Zeinalzadeh M, Basirat Z, Esmailpour M. Efficacy of letrozole in ovulation induction compared to that of clomiphene citrate in patients with polycystic ovarian syndrome. J Reprod Med 2010;55:36-40.
10. Gurates B, Parmaksiz C, Kilic G, Celik H, Kumru S, Simsek M. Treatment of symptomatic uterine leiomyoma with letrozole. Reprod Biomed Online 2008;17:569-574.
11. Barker LC, Brand IR, Crawford SM. Sustained effect of the aromatase inhibitors anastrozole and letrozole on endometrial thickness in patients with endometrial hyperplasia and endometrial carcinoma. Curr Med Res Opin 2009;25:1105-1109.
12. Sohrabvand F, Ansari Sh, Bagheri M. Efficacy of combined metforminletrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Hum Reprod 2006;21:1432-1435.
13. Batukan C, Baysal B. Metformin improves ovulation and pregnancy rates in patients with polycystic ovary syndrome. Arch Gynecol Obstet 2001;265:124-127.
14. Vandermolen DT, Ratts VS, Evans WS, Stovall DW, Kauma SW, Nestler JE. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil. Steril.;2001;75:310-315.
15. Ozcelik B, Turkyilmaz C, Ozgun MT, Serin IS, Batukan C, Ozdamar S, Ozturk A. Prevention of paclitaxel and cisplatin induced ovarian damage in rats by a gonadotropin-releasing hormone agonist. Fertil. Steril. 2010;93:1609-1614.
16. Souza AZ, Fonseca AM, Izzo VM, Clauzet RM, Salvatore CA. Ovarian histology and function after total abdominal hysterectomy. Obstet Gynecol 1986;68:847-849.
17. Bulun SE, Fang Z, Imir G, Gurates B, Tamura M, Yilmaz B, Langoi D, et al. Aromatase and endometriosis. Semin Reprod Med 2004;22:45-50.
18. Lamb HM, Adkins JC. Letrozole. A review of its use in postmenopausal women with advanced breast cancer. Drugs 1998;56:1125-1140.
19. Mitwally MF, Biljan MM, Casper RF. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Obstet Gynecol 2005;192:381-386.
20. Fisher SA, Reid RL, Van Vugt DA, Casper RF. A randomized doubleblind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. Fertil. Steril. 2002;78:280-285.
21. Yildirim G, Attar R, Ozkan F, Kumbak B, Ficicioglu C, Yesildaglar N. The effects of letrozole and melatonin on surgically induced endometriosis in a rat model: A preliminary study. Fertil. Steril. 2010;93:1787-1792.